Kyorin Pharma Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Tokyo Japan (1923)
Status: No NME R&D (1923)

Organization Overview

First Clinical Trial
2007
NCT00512785
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Kyorin Pharmaceutical Co.,Ltd